209 related articles for article (PubMed ID: 1575454)
21. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation?
Freed CR; Leehey MA; Zawada M; Bjugstad K; Thompson L; Breeze RE
J Neurol; 2003 Oct; 250 Suppl 3():III44-6. PubMed ID: 14579124
[TBL] [Abstract][Full Text] [Related]
22. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.
Cochen V; Ribeiro MJ; Nguyen JP; Gurruchaga JM; Villafane G; Loc'h C; Defer G; Samson Y; Peschanski M; Hantraye P; Cesaro P; Remy P
Mov Disord; 2003 Aug; 18(8):928-32. PubMed ID: 12889084
[TBL] [Abstract][Full Text] [Related]
23. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
[TBL] [Abstract][Full Text] [Related]
24. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.
Lindvall O; Brundin P; Widner H; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD
Science; 1990 Feb; 247(4942):574-7. PubMed ID: 2105529
[TBL] [Abstract][Full Text] [Related]
25. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
26. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
27. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
28. [Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
Sautter J; Kupsch A; Oertel WH; Earl CD
Zentralbl Neurochir; 1995; 56(4):161-7. PubMed ID: 8571694
[TBL] [Abstract][Full Text] [Related]
29. Transplantation in the treatment of paralysis agitans (Parkinson's disease).
Fazzini E
J Am Osteopath Assoc; 1992 Oct; 92(10):1255-60. PubMed ID: 1459872
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
Wenning GK; Odin P; Morrish P; Rehncrona S; Widner H; Brundin P; Rothwell JC; Brown R; Gustavii B; Hagell P; Jahanshahi M; Sawle G; Björklund A; Brooks DJ; Marsden CD; Quinn NP; Lindvall O
Ann Neurol; 1997 Jul; 42(1):95-107. PubMed ID: 9225690
[TBL] [Abstract][Full Text] [Related]
31. Computer assisted CT-guided stereotactic transplantation of foetal ventral mesencephalon to the caudate nucleus and putamen in Parkinson's disease.
Molina H; Quiñones R; Ortega I; Alvarez L; Muñoz J; Gonzalez C; Suárez C
Acta Neurochir Suppl (Wien); 1993; 58():17-9. PubMed ID: 8109284
[TBL] [Abstract][Full Text] [Related]
32. First human ventral mesencephalon and striatum cografting in a Parkinson patient.
Lee CC; Lin SZ; Wang Y; Lin JJ; Liu JY; Chen GJ; Chiang YH; Liu JC; Zhou FC
Acta Neurochir Suppl; 2003; 87():159-62. PubMed ID: 14518545
[TBL] [Abstract][Full Text] [Related]
33. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
[TBL] [Abstract][Full Text] [Related]
34. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE
J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610
[TBL] [Abstract][Full Text] [Related]
35. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
[TBL] [Abstract][Full Text] [Related]
36. [Medial posteroventral pallidotomy for the treatment of Parkinson's disease].
Krauss JK; Grossman RG; Lai EC; Schwartz K; Jankovic J
Zentralbl Neurochir; 1997; 58(4):153-62. PubMed ID: 9487651
[TBL] [Abstract][Full Text] [Related]
37. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.
Lindvall O; Rehncrona S; Brundin P; Gustavii B; Astedt B; Widner H; Lindholm T; Björklund A; Leenders KL; Rothwell JC; Frackowiak R; Marsden D; Johnels B; Steg G; Freedman R; Hoffer BJ; Seiger A; Bygdeman M; Strömberg I; Olson L
Arch Neurol; 1989 Jun; 46(6):615-31. PubMed ID: 2786405
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Piccini P; Pavese N; Hagell P; Reimer J; Björklund A; Oertel WH; Quinn NP; Brooks DJ; Lindvall O
Brain; 2005 Dec; 128(Pt 12):2977-86. PubMed ID: 16246865
[TBL] [Abstract][Full Text] [Related]
40. [Cell transplantation therapy for Parkinson's disease].
Nakao N; Uematsu Y; Itakura T
Nihon Rinsho; 2000 Oct; 58(10):2084-90. PubMed ID: 11068451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
